Search Blog
December 2013
« Nov   Jan »


Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation


By PrimeTimeMedia LLC

New York, December 12, 2013 / Accesswire / – Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Facebook Inc(NASDAQ:FB), BlackBerry Ltd(NASDAQ:BBRY), Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA), Nokia Corporation (ADR)(NYSE:NOK).

Facebook Inc(NASDAQ:FB): Instagram Direct, a new service being launched at the mobile photo-sharing platform’s NYC event , allows Instagram users to privately send photos and videos to up to 15 users. The photos can be accessed via Instagram’s main feed, and are complemented by a group chat feature.Om Malik previously reported Instagram was prepping a private messaging service. Though much attention is being given to how Direct compares to Snapchat, which Facebook reportedly tried to buy for $3B+, it’s arguably more a response to the rise of mobile messaging platforms such as WhatsApp, Kik, Line, and Viber, particularly in international markets.Those messaging platforms are viewed as a threat to Facebook’s mobile engagement rates, particularly as they develop app/services ecosystems around them. WhatsApp alone has 350M+ monthly active users (MAUs); Instagram reached 150M in September, and Facebook proper is at 1.19B.

Free Urgent Insider Catalyst Report For FB Available Here: (Or Copy and paste the URL into your browser)

An analyst from Citigroup gave a sell rating to BlackBerry Ltd(NASDAQ:BBRY) stating that the firm is still struggling and its better to break it into some parts rather than a complete company.

Ehud Gelblum set $4 price target and added that the management does not seem to be too keen on breaking the firm. Gelblum opined that there is no clarity on what the new management looks to focus, software or handset business.

The analyst also felt that a total shutdown would be expensive and costs may be over $1 billion whereas purchase commitments would be about $2.9 billion.

Free Urgent Insider Catalyst Report For BBRY Available Here: (Or Copy and paste the URL into your browser)

Ariad Pharmaceuticals, Inc.(NASDAQ:ARIA) is trying to convince the FDA that its blood cancer drug, Iclusig, should be allowed back on the market after being pulled due to excessive risk of blood clotting. The drug is still on the market in Europe, however, after the European Medicines Agency, or EMA, put forth a set of guidelines for the drug’s use. Ariad is hoping for a similar decision from the FDA next year.

Free Urgent Insider Catalyst Report For ARIA Available Here: (Or Copy and paste the URL into your browser)

An Indian court ruled Thursday that Nokia Corporation (ADR)(NYSE:NOK)  may transfer a factory seized by tax authorities to Microsoft as part of the Finnish communications giant’s 5.4 billion euro ($7.2 billion) sale of its devices and services unit. 

The ruling by the Delhi High Court coincided with a deadline after which Nokia had said the factory in the southeastern city of Chennai would be excluded from the Microsoft deal and might have to close. At least 8,000 workers are employed at the factory, which makes basic phone handsets, and some 25,000 subcontractors are dependent on its business, according to court filings.

Free Urgent Insider Catalyst Report For NOK Available Here: (Or Copy and paste the URL into your browser)  is an investment community that Focuses on MicroCap Securities. is an  authorative authentic Google News Site and  Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit   for more details. Get an edge on the market with our Premium News Alerts   that are FREE for a limited time at Follow us on Facebook: Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126.  (SMS alerts are free, however data rates may apply, check your wireless plan for details.)